# A top–down neural circuit for affective-motivational responses of pain relief induced by electroacupuncture

**Authors:** Hui Liu, Xin Jia, Zouqin Huang, Yong Xia, Jun Rong, Meiyu Chen, Can Wang, Chuan Qin, Jiaqi Lu, Qiuyong Li, Xueyong Shen, Ling Zhang, Sheng Liu

PMC · DOI: 10.1186/s13020-026-01349-5 · Chinese Medicine · 2026-03-01

## TL;DR

The study shows that electroacupuncture can relieve chronic pain and improve mood by activating a specific brain circuit.

## Contribution

The paper identifies a top-down neural circuit involving the infralimbic cortex and nucleus accumbens that mediates the affective-motivational effects of electroacupuncture.

## Key findings

- EA-induced analgesia and positive affective responses occur only in pain states.
- Activation of IL glutamatergic neurons and the IL-NAc shell pathway is necessary for EA's effects.
- EA reduces anxiety and depressive-like behaviors in chronic pain models.

## Abstract

Peripheral neuromodulation, which can be considered as a flow of signals from the body to the brain, influences mental and psychological states. However, whether peripheral neuromodulation, particularly electroacupuncture (EA), may regulate specific neural circuits and evoke affective‒motivational responses remains elusive. Here, we investigate the affective-motivational responses of pain relief following the application of EA in human and animal models in the context of pain.

The conditioned place preference (CPP), open field test and elevated plus maze tests were used to examine the affective‒motivational responses of pain relief induced by EA in different animal models of pain. EA at acupoint ST36 (2 Hz) was administered. Multi‒electrode array recording, optogenetics, retrograde neuronal tracing, chemogenetics and immunohistochemistry were used to explore the neural circuit mechanisms involved. rAAV virus were used to identify the target projection neurons. A battery of self-report questionnaire was used to assess affective‒motivational responses after EA in patients with chronic low back pain.

EA analgesia induced CPP only in pain states in different animal models of pain. Chronic pain induced negative affective valence of pain. EA attenuated anxious- or depressive-like behaviors in spared nerve injury (SNI) rats. EA robustly activated glutamatergic neurons in the infralimbic cortex (IL) in a pain-dependent manner. The optogenetic activation of IL glutamatergic (ILGlu) neurons mimicked EA-induced analgesia and CPP whereas their inhibition reversed the effects promoted by EA. Furthermore, the IL-nucleus accumbens (NAc) shell pathway was activated by EA in SNI rats. Inhibition of ILGlu to the NAc shell reversed EA-induced analgesia, CPP and anxiolytic-like behaviors. In addition, we identified that activation of ILGlu to nucleus accumbens shellGABA projection is necessary for EA induced analgesia, CPP and anxiolytic-like behaviors.

These results illustrate an example in which the emotional dimension of pain is directly influenced through the peripheral neuromodulation and provide the basis for the use of EA to target top down neural circuits to relieve chronic pain in psychological and clinical situations.

ChiCTR1800020029.

The online version contains supplementary material available at 10.1186/s13020-026-01349-5.

## Full-text entities

- **Genes:** Gabrg1 (gamma-aminobutyric acid type A receptor subunit gamma 1) [NCBI Gene 14405] {aka GabaA, GabaA/BZ}, Camk2d (calcium/calmodulin-dependent protein kinase II, delta) [NCBI Gene 108058] {aka 2810011D23Rik, 8030469K03Rik, CaMK II, [d]-CaMKII}, Sp6 (trans-acting transcription factor 6) [NCBI Gene 83395] {aka 1110025J03Rik, Epfn, Klf14}, Gria1 (glutamate ionotropic receptor AMPA type subunit 1) [NCBI Gene 50592] {aka GluA1, gluR-A}, Gria2 (glutamate ionotropic receptor AMPA type subunit 2) [NCBI Gene 29627] {aka GluA2, GluR-K2, GluR2, gluR-B}, Fos (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 14281] {aka D12Rfj1, c-fos, cFos}, Fos (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 314322] {aka c-fos}, Slc17a6 (solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6) [NCBI Gene 140919] {aka 2900073D12Rik, DNPI, VGLUT2}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 24383] {aka BARS-38, Gapd}, Ctbs (chitobiase) [NCBI Gene 74245] {aka 2210401K11Rik, CTB}, Eif1a (eukaryotic translation initiation factor 1A) [NCBI Gene 13664] {aka Ef1a, Eftu, Eif4c, eIF-1A, eIF-4C}, Pcyt1b (phosphate cytidylyltransferase 1B, choline) [NCBI Gene 286936] {aka CCT-beta, CTB, Cctbeta}, Agxt (alanine--glyoxylate aminotransferase) [NCBI Gene 24792] {aka AGT, SPT, Spat}, Slc17a6 (solute carrier family 17 member 6) [NCBI Gene 84487] {aka Dnpi, Vglut2}
- **Diseases:** allodynia (MESH:D006930), Chronic pain (MESH:D059350), depression (MESH:D003866), EPM (MESH:D006937), neuropathic (MESH:D009437), hypersensitivity (MESH:D004342), MIA (MESH:C562377), neuropsychiatric comorbidities (MESH:C000631768), infection (MESH:D007239), lethargy (MESH:D053609), opioid overdose (MESH:D000083682), arthritis (MESH:D001168), SNI (MESH:D000080902), Spinal Cord Injury (MESH:D013119), analgesia (MESH:D000699), neck pain (MESH:D019547), Chronic low back pain (MESH:D017116), acute and chronic pain (MESH:D059787), knee pain (MESH:D046788), fatigue (MESH:D005221), behavioral impairments (MESH:D001523), anxiety (MESH:D001007), CPP (MESH:D000073397), sinus bradycardia (MESH:D012804), headaches (MESH:D006261), incisional injury pain (MESH:D000069290), Pain (MESH:D010146)
- **Chemicals:** dopamine (MESH:D004298), PBS (MESH:D007854), polyA (MESH:D011061), serotonin (MESH:D012701), cobalt chloride (MESH:C018021), polystyrene (MESH:D011137), NBQX (MESH:C062865), Sucrose (MESH:D013395), PFA (MESH:C003043), Muscimol (MESH:D009118), Alexa Fluor 488 (MESH:C000711379), baclofen (MESH:D001418), phenylmethane sulfonyl fluoride (MESH:C003614), AMPA (MESH:D018350), NaHCO3 (MESH:D017693), Clozapine oxide (-), Alexa Fluor 647 (MESH:C569686), CNO (MESH:C079149), penicillin (MESH:D010406), glutamate (MESH:D018698), SDS (MESH:D012967), CaCl2 (MESH:D002122), GABA (MESH:D005680), noradrenaline (MESH:D009638), M/B (MESH:D008751), water (MESH:D014867), isoflurane (MESH:D007530), benzylpenicillin sodium (MESH:D010400), Monosodium iodoacetate (MESH:D019807), pentobarbital sodium (MESH:D010424), saline (MESH:D012965), MgCl2 (MESH:D015636), phosphate (MESH:D010710)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Rodentia (rodent, order) [taxon 9989], adeno-associated virus 2 (no rank) [taxon 10804], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** H134R
- **Cell lines:** /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12950241/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12950241/full.md

---
Source: https://tomesphere.com/paper/PMC12950241